Derivation of Functional Neurons from Human Adult Cells by Nonviral Gene Delivery
通过非病毒基因传递从人类成体细胞衍生功能神经元
基本信息
- 批准号:8315979
- 负责人:
- 金额:$ 23.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdultBiochemicalBrainCell Culture TechniquesCell TherapyCellsCentral Nervous System DiseasesClinicalClinical TrialsCorpus striatum structureDNADeep Brain StimulationDerivation procedureDoseDoxycyclineElectrophysiology (science)EngraftmentEpilepsyEthical IssuesEthicsFaceFetal TissuesFetusFiberFibroblastsFrequenciesHumanHuntington DiseaseIn VitroInterventionLevodopaMethodsMusNatureNeurodegenerative DisordersNeuronsParkinson DiseasePatientsPropertyReplacement TherapyReportingRiskScheduleSolutionsSourceStem cellsStrokeSubfamily lentivirinaeTeratomaTherapeuticTimeTranscription factor genesTransfectionTransplantationViralWithdrawalcell typecellular engineeringclinical applicationdopaminergic neuroneffective therapyembryonic stem cellfetalhuman embryonic stem cellimprovedinduced pluripotent stem cellinterestneurogenesisnon-viral gene deliverypolyacrylamide gelsprogenitortranscription factortransdifferentiationtransgene expressionvector
项目摘要
DESCRIPTION (provided by applicant): Most debilitating neurodegenerative diseases lack effective treatment options. Cell replacement therapy has been proposed as a promising long-term solution. However, procurement of the appropriate cells for therapy has been a significant challenge. Fetal tissue-derived neurons, embryonic stem cell-derived neurons, and induced pluripotent stem cell-derived neurons all suffer from concerns of ethical issues and/or teratoma formation. Transdifferentiation, where an adult cell type can be reprogrammed to another adult cell type of distinct lineage without going through complete de-differentiation to a pluripotent state, represents an attractive approach to generate cells rid of these shortcomings. Neuronal transdifferentiation (NTD) was most recently demonstrated by Wernig et al., where a delivery of Brn2, Ascl2, and Myt1l transcription factors (TFs) to mouse and human fibroblasts converted them into functional neurons with up to 20% efficiency, referred to as induced neuronal (iN) cells. These iNs are postmitotic and do not pass through a proliferative progenitor state, attributes making them an attractive cell source for cell-based therapy of CNS disorders such as epilepsy, stroke, Huntington disease, and Parkinson's disease. However, since these iNs have been generated by lentiviruses, an alternative derivation strategy must be developed for clinical applications. In our preliminary studies we have succeeded in generating mouse and human fibroblasts expressing the pan-neuronal markers Tuj1 and MAP2 by nonviral delivery of the reported TFs. The transdifferentiation efficiency is low, but we believe there is ample room for improvement. The objective of this proposal is to develop effective strategies to generate functional neurons from adult human cells using nonviral methods. We propose to pursue the following specific aims: (1) Optimize efficiency of neuronal transdifferentiation from human adult cells by nonviral vectors; (2) Investigate effects of substrate properties on efficiency of neurona transdifferentiation.
PUBLIC HEALTH RELEVANCE: Most debilitating neurodegenerative diseases lack effective treatment options. Cell replacement therapy has been proposed as a promising long-term solution. This proposal aims to develop effective strategies to generate functional neurons from adult human cells using nonviral methods, making them an attractive cell source for cell-based therapy of CNS disorders such as epilepsy, stroke, Huntington disease, and Parkinson's disease.
描述(申请人提供):大多数衰弱的神经退行性疾病缺乏有效的治疗选择。细胞替代疗法已被认为是一种很有前途的长期解决方案。然而,获取用于治疗的适当细胞一直是一个重大挑战。胎儿组织来源的神经元、胚胎干细胞来源的神经元和诱导的多能干细胞来源的神经元都受到伦理问题和/或畸胎瘤形成的影响。转分化,即一种成体细胞类型可以被重新编程为另一种不同谱系的成体细胞类型,而不需要经历完全去分化到多能性状态,这是一种有吸引力的方法来产生摆脱这些缺点的细胞。Wernig等人最近证实了神经元转分化(NTD),将Brn2、Ascl2和Myt1转录因子(TF)导入鼠和人成纤维细胞,将它们转化为功能神经元,效率高达20%,称为诱导神经元(IN)细胞。这些INS是有丝分裂后的,不会经历增殖的祖细胞状态,这使得它们成为基于细胞的治疗中枢神经系统疾病(如癫痫、中风、亨廷顿病和帕金森病)的有吸引力的细胞来源。然而,由于这些INS是由慢病毒产生的,因此必须开发一种替代的衍生策略用于临床应用。在我们的初步研究中,我们已经成功地通过非病毒传递已报道的TF来产生表达泛神经元标记Tuj1和Map2的鼠和人成纤维细胞。转分化效率很低,但我们认为还有很大的改进空间。这项建议的目的是开发有效的策略,使用非病毒方法从成人细胞中产生功能神经元。我们提出了以下具体目标:(1)优化非病毒载体对成人细胞转分化效率的影响;(2)研究底物性质对神经细胞转分化效率的影响。
与公共卫生相关:大多数使人衰弱的神经退行性疾病缺乏有效的治疗选择。细胞替代疗法已被认为是一种很有前途的长期解决方案。这项建议旨在开发有效的策略,使用非病毒方法从成人细胞中生成功能神经元,使其成为基于细胞的治疗中枢神经系统疾病(如癫痫、中风、亨廷顿病和帕金森病)的有吸引力的细胞来源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KAM W LEONG其他文献
KAM W LEONG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KAM W LEONG', 18)}}的其他基金
Focused Ultrasound-mediated Delivery of Gene-editing Elements to the Brain for Neurodegenerative Disorders
聚焦超声介导的基因编辑元件递送至大脑以治疗神经退行性疾病
- 批准号:
9810901 - 财政年份:2019
- 资助金额:
$ 23.55万 - 项目类别:
Evaluation of nonviral gene editing systems in the brain assisted by focused ultrasound
聚焦超声辅助下大脑非病毒基因编辑系统的评估
- 批准号:
10658371 - 财政年份:2019
- 资助金额:
$ 23.55万 - 项目类别:
Focused Ultrasound-mediated Delivery of Gene-editing Elements to the Brain for Neurodegenerative Disorders
聚焦超声介导的基因编辑元件递送至大脑以治疗神经退行性疾病
- 批准号:
10248386 - 财政年份:2019
- 资助金额:
$ 23.55万 - 项目类别:
Focused Ultrasound-mediated Delivery of Gene-editing Elements to the Brain for Neurodegenerative Disorders
聚焦超声介导的基因编辑元件递送至大脑以治疗神经退行性疾病
- 批准号:
10619032 - 财政年份:2019
- 资助金额:
$ 23.55万 - 项目类别:
Engineering Polymers to Scavenge DAMPs in Arthritis and Lupus
工程聚合物可清除关节炎和狼疮中的 DAMP
- 批准号:
9761982 - 财政年份:2018
- 资助金额:
$ 23.55万 - 项目类别:
Engineering Polymers to Scavenge DAMPs in Arthritis and Lupus
工程聚合物可清除关节炎和狼疮中的 DAMP
- 批准号:
10470805 - 财政年份:2018
- 资助金额:
$ 23.55万 - 项目类别:
Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screening
用于疾病建模和神经精神药物筛选的脑类器官和血管的集成微生理系统
- 批准号:
10055998 - 财政年份:2018
- 资助金额:
$ 23.55万 - 项目类别:
Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screening
用于疾病建模和神经精神药物筛选的脑类器官和血管的集成微生理系统
- 批准号:
10361499 - 财政年份:2018
- 资助金额:
$ 23.55万 - 项目类别:
Engineering Polymers to Scavenge DAMPs in Arthritis and Lupus
工程聚合物可清除关节炎和狼疮中的 DAMP
- 批准号:
10220851 - 财政年份:2018
- 资助金额:
$ 23.55万 - 项目类别:
Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screening
用于疾病建模和神经精神药物筛选的脑类器官和血管的集成微生理系统
- 批准号:
9401926 - 财政年份:2018
- 资助金额:
$ 23.55万 - 项目类别:
相似海外基金
Micro-invasive biochemical sampling of brain interstitial fluid for investigating neural pathology
脑间质液微创生化取样用于研究神经病理学
- 批准号:
10517496 - 财政年份:2020
- 资助金额:
$ 23.55万 - 项目类别:
Micro-invasive biochemical sampling of brain interstitial fluid for investigating neural pathology
脑间质液微创生化取样用于研究神经病理学
- 批准号:
10304119 - 财政年份:2020
- 资助金额:
$ 23.55万 - 项目类别:
Biochemical Consequences of Regiospecific Metabolic Bias in the Brain
大脑区域特异性代谢偏差的生化后果
- 批准号:
10356172 - 财政年份:2020
- 资助金额:
$ 23.55万 - 项目类别:
Biochemical Consequences of Regiospecific Metabolic Bias in the Brain
大脑区域特异性代谢偏差的生化后果
- 批准号:
10159813 - 财政年份:2020
- 资助金额:
$ 23.55万 - 项目类别:
Micro-invasive biochemical sampling of brain interstitial fluid for investigating neural pathology
脑间质液微创生化取样用于研究神经病理学
- 批准号:
9885472 - 财政年份:2020
- 资助金额:
$ 23.55万 - 项目类别:
Micro-invasive biochemical sampling of brain interstitial fluid for investigating neural pathology
脑间质液微创生化取样用于研究神经病理学
- 批准号:
10090597 - 财政年份:2020
- 资助金额:
$ 23.55万 - 项目类别:
Biochemical Consequences of Regiospecific Metabolic Bias in the Brain
大脑区域特异性代谢偏差的生化后果
- 批准号:
10569574 - 财政年份:2020
- 资助金额:
$ 23.55万 - 项目类别:
Linking Connectomics to Biochemical Trajectories of Aging: How the Human Brain Ages Differentially in Key Regions of the Default Mode Network
将连接组学与衰老的生化轨迹联系起来:人脑默认模式网络关键区域的衰老方式如何差异
- 批准号:
9447437 - 财政年份:2017
- 资助金额:
$ 23.55万 - 项目类别:
Linking Connectomics to Biochemical Trajectories of Aging: How the Human Brain Ages Differentially in Key Regions of the Default Mode Network
将连接组学与衰老的生化轨迹联系起来:人脑默认模式网络关键区域的衰老方式如何差异
- 批准号:
9926788 - 财政年份:2017
- 资助金额:
$ 23.55万 - 项目类别:
Linking Connectomics to Biochemical Trajectories of Aging: How the Human Brain Ages Differentially in Key Regions of the Default Mode Network
将连接组学与衰老的生化轨迹联系起来:人脑默认模式网络关键区域的衰老方式如何差异
- 批准号:
10159810 - 财政年份:2017
- 资助金额:
$ 23.55万 - 项目类别: